Christa L. Tanganyika-de Winter, BSc.
Christa de Winter is Research Technician in the DMD Genetic Therapy Group at the Human Genetics Department (LUMC) since November 2003. Her Analyse paper won the Anna Wichersprijs for best Analyse paper in 2007-2008.
Publication list
Nellist, M., Goedbloed, M.A., de Winter, C.L., Verhaaf, B., Jankie A., Reuser, A.J., van den Ouweland, A.M., van der Sluijs, P. and Halley, (D.J. 2002) Identification and characterization of the interaction between tuberin and 14-3-3zeta. J Biol Chem 277, 39417-24.
Aartsma-Rus,A., De Winter,C.L., Janson,A.A., Kaman,W.E., van Ommen,G.J., Den Dunnen,J.T., and van Deutekom,J.C. (2005) Functional analysis of 114 exon-internal AONs for targeted DMD exon skipping: indication for steric hindrance of SR protein binding sites. Oligonucleotides., 15, 284-297.
Aartsma-Rus,A., Janson,A.A., Heemskerk,J.A., De Winter,C.L., van Ommen,G.J., and van Deutekom,J.C. (2006) Therapeutic modulation of DMD splicing by blocking exonic splicing enhancer sites with antisense oligonucleotides. Ann.N.Y.Acad.Sci., 1082, 74-76.
De Winter, C.L. and
Aartsma-Rus, A. (2007) RNA-therapie voor de ziekte van Duchenne: Minder is meer.
Analyse 07: 192-196. (Anna Wichersprijs for best paper in 2007-2008).
Aartsma-Rus A, van Vliet L, Hirschi M, Janson, A.A., Heemskerk, J.A. De Winter, C.L. et al. (2008) Guidelines for antisense oligonucleotide design and insight in splice modulating mechanisms. Mol Ther ; epub 23 Sept
Van Vliet L, de Winter CL, van Deutekom JCT....and Aartsma-Rus A (2008) Assessment of the feasibility of exon 45-55 multiexon skipping for Duchenne muscular dystrophy. BMC Med Genet, 9:105
Heemskerk JA, de Winter CL, De Kimpe S...and Aartsma-Rus A (2009) In vivo comparison of 2'O-methyl-PS and morpholino antisense oligonucleotides for DMD exon skipping. J Gene Med ; 11:257-66
Heemskerk JA, de Winter CL, van Ommen G-J,
van Deutekom JCT and Aartsma-Rus A:
Development of antisense-mediated exon skipping as a treatment for Duchenne
muscular dystrophy. Annals of the NY Acad Science 2009; 1175: 71-9.
Popplewell LJ, Adkin C, Arechavala-Gomeza V, Aartsma-Rus A, de Winter CL
et al: Comparative analysis of antisense oligonucleotide sequences targeting
exon 53 of the human DMD gene:
Implications for future clinical trials. Neuromuscular Disorders 2010; 20:
102-110.
Van Putten M, Winter CL, van
Roon-Mom W, van Ommen G-JB, 't Hoen PAC and Aartsma-Rus A: A mild exercise
regime does not affect disease parameters in the mdx mouse. Neuromuscular
Disorders 2010; 20: 273-80
Heemskerk JA, de Winter CL, van Kuik P….Aartsma-Rus A, and van Deutekom JCT: Pre-clinical PK and PD Studies on 2’O-Methyl-Phosphorothioate RNA Antisense Oligonucleotides in the mdx mouse model. Mol Ther 2010; 18: 1210-7